Degenerative disc disease is one of the leading causes of neck and low back pain in adults. This medical condition results in many symptoms. It is caused by wear and tear on the spinal discs. In this article, we are going to talk about Stem Cell treatment of Degenerative Disc Disease.
Aside from back and neck aches, degenerative disc disease can result in:
- Hot or shooting pains
- A “giving out” sensation
- Muscle spasms and tension
- And more
The most common symptom of this condition is constant and low-level pain. Chronic pain can make it difficult to live a normal life. Because of the discomfort that comes from degenerative disc disease, researchers are looking for innovative treatments to help patients live more comfortably.
Recent Phase III Trial Results for Stem Cell Therapies
A recent randomized Phase III trial has shown that stem cell injections can help patients with degenerative disc disease. According to the study, a single injection provided long-term relief of back pain. The study was conducted using stem cell products from Mesoblast Limited, an Australian regenerative medicine provider.
Representatives from the company hope to meet with the Food and Drug Administration (FDA) to speed up the approval of their product. The product in question is known as “remestemcel-L.” The company has been developing this stem cell product for several years.
Like many stem cell treatments, the product is made using bone marrow to harvest mesenchymal stem cells. Those cells are then injected into patients’ bodies to reduce inflammation. The product inhibits the development of certain inflammatory substances. Decreased inflammation reduces the patient’s pain.
According to the trial report, sixty percent of the injected patients reported little to no pain after a year. After two years, 54% reported minimal or no discomfort. The injections provided the most pain relief for patients who were in the early stages of the disease.
Reduced Use of Opioids
Studies like the one discussed above have given many patients and medical professionals confidence in the potential of stem cells. In the study by Mesoblast Limited, more than 400 volunteers participated. Many of the patients who experienced pain relief decreased their use of opioids. Across the study group, opioid use declined by 40%.
Patients in the control group who received a saline injection actually increased their use of opioids. Because of this, the company hopes that the FDA will fast-track the approval of remestemcel-L as a standard treatment for degenerative disc disease.
Future studies will be necessary to determine the full potential of stem cell therapies. Still, many patients have experienced significant improvements in their health and wellbeing by using stem cell therapies. If you are interested in using stem cell treatment for Degenerative Disc Disease contact a care coordinator today to learn more!